Drug middlemen illegally drive up the cost of insulin, FTC says
Federal regulators are accusing the country’s three largest pharmacy benefit managers of illegally driving up the cost of insulin in the U.S., while making it harder for patients to obtain cheaper versions of the life-saving drug. The companies — CVS-owned Caremark Rx, Cigna Group’s Express Scripts and UnitedHealth Group’s Optum Rx — acted in ways […]